A novel multi-epitope peptide vaccine against cancer: an in silico approach

DOI10.1016/J.JTBI.2014.01.018MaRDI QIDQ2632772zbMATH OpenOpenAlexWikidataFDO

Authors Navid Nezafat, Younes Ghasemi, Gholamreza Javadi, Mohammad Javad Khoshnoud, Eskandar Omidinia

Publication date 15 May 2019

Published in Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.jtbi.2014.01.018

zbMATH Keywords

bioinformaticsimmunotherapyCTL responseadjuvantHTL response

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Recommendations

• Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells
• Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules
• Computational modeling of the immune response to tumor antigens
• Knowledge-based virtual screening of HLA-A*0201-restricted CD8\(^+\) T-cell epitope peptides from herpes simplex virus genome
• On immunotherapies and cancer vaccination protocols: a mathematical modelling approach

Cited in

(3)

• Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein
• Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules
• Knowledge-based virtual screening of HLA-A*0201-restricted CD8\(^+\) T-cell epitope peptides from herpes simplex virus genome

Describes a project that uses

Uses Software

• PSIPRED
• PROCHECK
• JCat
• PAComplex
• Frustratometer
• MODELLER
• ExPASy
• SOLpro

This page was built for publication: A novel multi-epitope peptide vaccine against cancer: an in silico approach

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2632772)